Suchergebnisse - "Drug Repositioning"

PubPharm (8)

1

Imidazoles and benzimidazoles as putative inhibitors of SARS-CoV-2 B.1.1.7 (Alpha) and P.1 (Gamma) variant spike glycoproteins: A computational approach

enthalten in: Chemické zvesti | 2021

von Yele, V. | Sanapalli, B. | Mohammed, A.

2

Identifying FDA-approved drugs with multimodal properties against COVID-19 using a data-driven approach and a lung organoid model of SARS-CoV-2 entry

enthalten in: Molecular medicine | 2021

von Duarte, R. | Copertino, D. | Iñiguez, L. | +7

3

COVID-19: molecular pathophysiology, genetic evolution and prospective therapeutics—a review

enthalten in: Archives of microbiology | 2021

von Raj, C. | Kandaswamy, D. | Danduga, R. | +2

4

Raloxifene as a treatment option for viral infections

enthalten in: The journal of microbiology | 2021

von Hong, S. | Chang, J. | Jeong, K. | +1

5

COVID-19: Analysis of Drug Repositioning Practice

enthalten in: Pharmaceutical chemistry journal | 2021

von Savosina, P. | Druzhilovskii, D. | Poroikov, V.

6

Chloroquine and Hydroxychloroquine for the Treatment of COVID-19 : Review and Appraisal of Current Evidence

enthalten in: Journal of National Black Nurses' Association : JNBNA | 2020

von Powell-Young, Y. | Alzaghari, O. | Reyes-Miranda, C. | +6

7

COVID-19: Antiviral Agents, Antibody Development and Traditional Chinese Medicine

enthalten in: Virologica Sinica | 2020

von Guan, W. | Lan, W. | Zhang, J. | +6

8

Repurposing metocurine as main protease inhibitor to develop novel antiviral therapy for COVID-19

enthalten in: Structural chemistry | 2020

von Jain, R. | Mujwar, S.

1
[1]